Procter & Gamble (PG-Quote) announced that it plans to sell its prescription drug division to Warner Chilcott (WCRX-Quote) on Monday, in a deal that will be worth $3.1 billion.
The move is in line with Procter & Gamble’s desire to shed non-core businesses that have experienced slower-than-average growth in recent years.
The deal marks a milestone for P&G’s new chief executive, Bob McDonald, who moved into his current position in July.
"We know that our shareholders don't reward us for size. They reward us for growth," said McDonald on a conference call. "We are going to do what we have to do to get the right portfolio of businesses together. We are focused on growth."
The sale is expected to be completed by the end of the year.
Disclosure I am long PG shares.
Interesting post excellent.
ReplyDeleteThis is really good idea that eliminate delay on toll roads by collecting the electronic tolls. According to the public are suffered with this toll problem and seeking help from the government to get rid of this problem. buy virtual number
ReplyDelete